Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 2245-2253

  Geng, Yuemei ^a,d   Berencsi, Klara ^a   Gyulai, Zsofia ^a   Valyi Nagy, Tibor ^b   Gonczol, Eva ^a   Trinchieri, Giorgio ^a,c  

^a WISTAR INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CELL STIMULATION; CHLAMYDOPHILA PNEUMONIAE; CYTOKINE RELEASE; GAMMA IRRADIATION; HISTOPATHOLOGY; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; STRAIN DIFFERENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COLONY COUNT, MICROBIAL; CYTOKINES; IMMUNOSUPPRESSION; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LUNG; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034063151     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.2245-2253.2000     Document Type: Article

References (61)

1. Augenbraun, M. H., P. M. Roblin, K. Chirgwin, D. Landman, and M. R. Hammerschlag. 1991. Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus. J. Clin. Microbiol. 29:401-402.
2. Bachmaier, K., N. Neu, L. de la Maza, S. Pal, A. Hessel, and J. M. Penninger. 1999. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283:1335-1339.
3. Berencsi, K., V. Endresz, D. Klurfeld, L. Kari, D. Kritchevsky, and E. Gonczol. 1998. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell Adhes. Commun. 5:39-47.
4. Campbell, L. A., E. R. O'Brien, A. L. Cappuccio, C. C. Kuo, S. P. Wang, D. Stewart, D. L. Patton, P. K. Cummings, and J. T. Grayston. 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues [see comments]. J. Infect. Dis. 172:585-588.
5. Carlin, J. M., and J. B. Weller. 1995. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures. Infect. Immun. 63:1870-1875.
6. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39-45.
7. Cotter, T. W., K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen, and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65:2145-2152.
8. Dai, W. J., W. Bartens, G. Kohler, M. Hufnagel, M. Kopf, and F. Brombacher. 1997. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J. Immunol. 158:5297-5304.
9. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
10. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157.
11. Fong, I. W., B. Chiu, E. Viira, M. W. Fong, D. Jang, and J. Mahony. 1997. Rabbit model for Chlamydia pneumoniae infection. J. Clin. Microbiol. 35: 48-52.
12. Forsey, T., S. Darougar, and J. D. Treharne. 1986. Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia. J. Infect. 12:145-152.
13. Gaydos, C. A., J. J. Eiden, D. Oldach, L. M. Mundy, P. Auwaerter, M. L. Warner, E. Vance, A. A. Burton, and T. C. Quinn. 1994. Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin. Infect. Dis. 19:157-160.
14. Gaydos, C. A., C. L. Fowler, V. J. Gill, J. J. Eiden, and T. C. Quinn. 1993. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. Clin. Infect. Dis. 17: 718-723.
15. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, and T. C. Quinn. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1614-1620.
16. Geng, Y., S. M. Savage, S. Razanai-Boroujerdi, and M. L. Sopori. 1996. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J. Immunol. 156:2384-2390.
17. Grayston, J. T. 1992. Infections caused by Chlamydia pneumoniae strain TWAR [see comments]. Clin. Infect. Dis. 15:757-761.
18. Grayston, J. T., M. B. Aldous, A. Easton, S. P. Wang, C. C. Kuo, L. A. Campbell, and J. Altman. 1993. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J. Infect. Dis. 168:1231-1235.
19. Grayston, J. T., L. A. Campbell, C. C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thom, and S. P. Wang. 1990. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161:618-625.
20. Grayston, J. T., V. K. Diwan, M. Cooney, and S. P. Wang. 1989. Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch. Intern. Med. 149:169-173.
21. Hahn, D. L., R. W. Dodge, and R. Golubjatnikov. 1991. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma [see comments]. JAMA 266:225-230.
22. Heinemann, M., M. Susa, U. Simnacher, R. Marre, and A. Essig. 1996. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 4:4872-4875.
23. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
24. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-receptor. Science 259:1742-1745.
25. Johansson, M., K. Schon, M. Ward, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails of induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65:1032-1044.
26. Kanamoto, Y., K. Ouchi, M. Mizui, M. Ushio, and T. Usui. 1991. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J. Clin. Microbiol. 29:816-818.
27. Kaukoranta-Tolvanen, S. S., T. Ronni, M. Leinonen, P. Saikku, and K. Laitinen. 1996. Expression of adhesion molecules an endothelial cells stimulated by Chlamydia pneumoniae. Microb. Pathog. 21:407-411.
28. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-846.
29. Kohno, K., J. Kataoka, T. Ohtsuki, Y. Suemoto, I. Okamoto, M. Usui, M. Ikeda, and M. Kurimoto. 1997. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1541-1550.
30. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
31. Kuo, C. C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841-849.
32. Laitinen, K., A. Laurila, L. Pyhala, M. Leinonen, and P. Saikku. 1997. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect. Immun. 65:4832-4835.
33. Laurila, A. L., L. Von Hertzen, and P. Saikku. 1997. Chlamydia pneumoniae and chronic lung diseases. Scand. J. Infect. Dis. Suppl. 104:34-36.
34. + T cells. J. Immunol. 154:5071-5079.
35. Magee, D. M., J. G. Smith, C. A. Bleicker, C. J. Carter, L. F. Bonewald, J. Schachter, and D. M. Williams. 1992. Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect. Immun. 60:1217-1220.
36. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471-481.
37. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-1204.
38. Marin, A., A. Karolyi, and A. Szalka. 1992. Prevalence of Chlamydia pneumoniae antibodies in Hungary. Eur. J. Clin. Microbiol. Infect. Dis. 11:139-142.
39. Marrie, T. J., J. T. Grayston, S. P. Wang, and C. C. Kuo. 1987. Pneumonia associated with the TWAR strain of Chlamydia. Ann. Intern. Med. 106:507-511.
40. Miller, S. T., M. R. Hammerschlag, K. Chirgwin, S. P. Rao, P. Roblin, M. Gelling, T. Stilerman, J. Schachter, and G. Cassell. 1991. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J. Pediatr. 118: 30-33.
41. Moazed, T. C., C. Kuo, J. T. Grayston, and L. A. Campbell. 1997. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175:883-890.
42. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
43. Montes, M., G. Cilla, M. Alcorta, and E. Perez-Trallero. 1992. High prevalence of Chlamydia pneumoniae infection in children and young adults in Spain [see comments]. Pediatr. Infect. Dis. J. 11:972-973.
44. Penttila, J. M., M. Anttila, M. Puolakkainen, A. Laurila, K. Varkila, M. Sarvas, P. H. Makela, and N. Rautonen. 1998. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect. Immun. 66:5113-5118.
45. Perry, L. L., K. Feilzer, and H. D. Caldwell. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol. 158:3344-3352.
46. Rothermel, C. D., J. Schachter, P. Lavrich, E. C. Lipsitz, and T. Francus. 1989. Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect. Immun. 57:2705-2711.
47. Saikku, P., M. Leinonen, K. Mattila, M. R. Ekman, M. S. Nieminen, P. H. Makela, J. K. Huttunen, and V. Valtonen. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-986.
48. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmaki, M. R. Ekman, V. Manninen, M. Manttari, M. H. Frick, and J. K. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study [see comments]. Ann. Intern. Med. 116:273-278.
49. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433-3440.
50. Shemer-Avni, Y., D. Wallach, and I. Sarov. 1988. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect. Immun. 56:2503-2506.
51. Shor, A., C. C. Kuo, and D. L. Patton. 1992. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82:158-161.
52. Szalay, G., C. H. Ladel, C. Blum, and S. H. Kaufmann. 1996. IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice. J. Immunol. 157:4746-4750.
53. Thom, D. H., S. P. Wang, J. T. Grayston, D. S. Siscovick, D. K. Stewart, R. A. Kronmal, and N. S. Weiss. 1991. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler. Thromb. 11:547-551.
54. Tournier, I., D. Bernuau, A. Poliard, D. Schoevaert, and G. Feldmann. 1987. Detection of albumin mRNAs in rat liver by in situ hybridization: usefulness of paraffin embedding and comparison of various fixation procedures. J. Histochem. Cytochem. 35:453-459.
55. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr. Opin. Immunol. 9:17-23.
56. Trinchieri, G. 1998. Interleukin-12: a cytokinc at the interface of inflammation and immunity. Adv. Immunol. 70:83-243.
57. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
58. Wang, S.-P., and J. T. Grayston. 1990. Population prevalence of antibody to Chlamydia pneumoniae, strain TWAR, p. 402-405. In W. R. Bowie, H. D. Caldwell, R. P. Jones, P.-A. Mardh, G. L. Ridgway, J. Schachter, W. E. Stamm, and M. E. Ward (ed.), Chlamydial infections. Cambridge University Press, Cambridge, United Kingdom.
59. Ward, M. E. 1995. The immunobiology and immunopathology of chlamydial infections. Acta Pathol. Microbiol. Immunol. Scand. 103:769-796.
60. Williams, D. M., D. M. Magee, L. F. Bonewald, J. G. Smith, C. A. Bleicker, G. I. Byrne, and J. Schachter. 1990. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect. Immun. 58: 1572-1576.
61. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672-676.